Published in Obesity and Diabetes Week, September 13th, 2004
While one study examines the beneficial role of hormones in women who experience early menopause, a second highlights the possible benefits of metformin in treating a prediabetes condition. A third study demonstrates that an insulin sensitizer could lessen the risk of diabetes for women with a common endocrine disorder.
During menopause, women experience endothelial dysfunction, which can lead to atherosclerosis. However, despite numerous studies on normal menopause and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.